Identifying Industry Margins with Unobserved Price Constraints: Structural Estimation on Pharmaceuticals
Pierre Dubois and
Laura Lasio
No 823, IDEI Working Papers from Institut d'Économie Industrielle (IDEI), Toulouse
Abstract:
We provide a method allowing identification of margins in an oligopoly price competition game when prices may not be freely chosen in some markets, for example due to regulation. We use our identification strategy to study the effects of regulatory constraints in the pharmaceutical industry. We provide the first structural estimation of price-cost margins on a regulated market with price constraints and show how to identify unknown possibly binding constraints thanks to three different markets (US, Germany and France) with varying regulatory constraints. We use the market for anti-ulcer drugs to identify whether regulation in France truly affects margins and prices and relate regulatory reforms to industry pricing equilibrium. Empirical results show that firms were especially constrained in price setting after the different reforms in 2004. Counterfactual simulations show that total spending significantly increased because of the new price regulation by displacing part of the demand from generics to branded drugs.
Keywords: empirical IO; price constraints; Bertrand competition; regulation; pharmaceuticals; antiulcer drugs (search for similar items in EconPapers)
JEL-codes: I18 L10 (search for similar items in EconPapers)
Date: 2014-02
New Economics Papers: this item is included in nep-com, nep-ind and nep-mkt
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (12)
Downloads: (external link)
http://idei.fr/sites/default/files/medias/doc/wp/2014/wp_idei_823.pdf Full text (application/pdf)
Related works:
Working Paper: Identifying Industry Margins with Unobserved Price Constraints: Structural Estimation on Pharmaceuticals (2018)
Working Paper: Identifying Industry Margins with Unobserved Price Constraints: Structural Estimation on Pharmaceuticals (2014)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:ide:wpaper:27918
Access Statistics for this paper
More papers in IDEI Working Papers from Institut d'Économie Industrielle (IDEI), Toulouse Contact information at EDIRC.
Bibliographic data for series maintained by ().